MENU
+Compare
ZVRA
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$8.72
Change
+$0.55 (+6.73%)
Capitalization
490.91M

ZVRA Zevra Therapeutics Forecast, Technical & Fundamental Analysis

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options... Show more

ZVRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ZVRA with price predictions
Nov 28, 2025

ZVRA's RSI Indicator climbs out of oversold territory

The RSI Oscillator for ZVRA moved out of oversold territory on November 10, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZVRA advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

ZVRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ZVRA as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ZVRA moved below its 50-day moving average on November 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ZVRA crossed bearishly below the 50-day moving average on November 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZVRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ZVRA entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ZVRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.686) is normal, around the industry mean (27.312). P/E Ratio (18.553) is within average values for comparable stocks, (52.442). ZVRA's Projected Growth (PEG Ratio) (10.667) is very high in comparison to the industry average of (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (5.780) is also within normal values, averaging (321.020).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZVRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
ZVRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ZVRA is expected to report earnings to rise 140.00% to -2 cents per share on March 11

Zevra Therapeutics ZVRA Stock Earnings Reports
Q4'25
Est.
$-0.02
Q3'25
Beat
by $0.02
Q2'25
Missed
by $2.25
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.27
The last earnings report on November 05 showed earnings per share of 0 cents, beating the estimate of -2 cents. With 1.10M shares outstanding, the current market capitalization sits at 490.91M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1180 Celebration Boulevard
Phone
+1 321 939-3416
Employees
69
Web
https://www.zevra.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRGIX7.43N/A
N/A
DWS RREEF Global Real Estate Secc Inst
RYMVX78.71N/A
N/A
Rydex S&P MidCap 400 Pure Value A
FCDCX34.76N/A
N/A
Fidelity Advisor Stock Selector Sm Cp C
CEMFX15.92N/A
N/A
Cullen Emerging Markets High Div I
EPGIX20.54N/A
N/A
EuroPac Gold I

ZVRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with AUTL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then AUTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
-2.10%
AUTL - ZVRA
38%
Loosely correlated
-2.90%
ACLX - ZVRA
38%
Loosely correlated
-2.03%
FULC - ZVRA
37%
Loosely correlated
-9.27%
IMTX - ZVRA
37%
Loosely correlated
-3.70%
OCUL - ZVRA
36%
Loosely correlated
-3.93%
More